A case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy after primary treatment of triple-negative breast cancer

We report a case of HER-2-positive recurrent breast cancer showing a clinically complete response to trastuzumab-containing chemotherapy 6 years after primary treatment of triple-negative breast cancer. The primary tumor was negative for HER-2 as determined by immunohistochemistry (IHC) and fluoresc...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Hideo, Kadoya, Takayuki, Kobayashi, Yoshie, Kajitani, Keiko, Sasada, Tatsunari, Emi, Akiko, Masumoto, Norio, Haruta, Rumi, Kataoka, Tsuyoshi, Oda, Miyo, Arihiro, Kouji, Okada, Morihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220638/
https://www.ncbi.nlm.nih.gov/pubmed/22059982
http://dx.doi.org/10.1186/1477-7819-9-146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220638/
https://www.ncbi.nlm.nih.gov/pubmed/22059982
http://dx.doi.org/10.1186/1477-7819-9-146

Ejemplares similares